DCH:NYSEDauch Corporation Analysis
Data as of 2026-03-28 - not real-time
$5.61
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Dauch Corp. (DCH) is trading at $5.61, which sits below its 20‑day SMA ($5.67) and 200‑day SMA ($6.04), indicating a short‑term downtrend, yet the MACD histogram is positive and the signal line turned bullish, suggesting a potential technical rebound toward the $6.46 resistance. The RSI at 42 points to neutral momentum, while the stock’s 30‑day volatility is high at 68% and beta of 1.5 underscores pronounced sensitivity to market swings. Fundamentally, the company trades at a low forward P/E of 5.7 and a price‑to‑book of 1.04, but the DCF‑derived fair value of $1.35 implies the market is pricing in a substantial premium, reflected in the 71% upside estimate from analyst targets. A crippling debt‑to‑equity ratio of 664 and negative free cash flow further highlight financial strain despite a modest operating cash flow of $0.41 B.
Analyst consensus remains bullish with a “Buy” rating and a median price target of $9.0, driven by DCH’s exposure to the growing EV and hybrid driveline market and recent strategic moves such as the inducement RSU awards to retain talent post‑business combination. Institutional interest is evident from Miller Value Partners’ new position, while the company’s presentation at the BofA Global Automotive Summit signals continued engagement with industry trends. However, the combination of high leverage, negative earnings and a DCF valuation far below current price injects considerable downside risk, tempering enthusiasm for longer horizons.
Analyst consensus remains bullish with a “Buy” rating and a median price target of $9.0, driven by DCH’s exposure to the growing EV and hybrid driveline market and recent strategic moves such as the inducement RSU awards to retain talent post‑business combination. Institutional interest is evident from Miller Value Partners’ new position, while the company’s presentation at the BofA Global Automotive Summit signals continued engagement with industry trends. However, the combination of high leverage, negative earnings and a DCF valuation far below current price injects considerable downside risk, tempering enthusiasm for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near the $5.07 support level with bullish MACD crossover
- Neutral RSI and high volatility suggest cautious positioning
- Recent RSU awards may stabilize management and operations
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst median target of $9.0 implies ~70% upside
- Exposure to EV drivetrain demand and recent business combination
- Institutional interest from Miller Value Partners
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- DCF fair value of $1.35 indicates significant overvaluation
- Excessive debt (Debt‑to‑Equity > 600) and negative free cash flow
- Persistent earnings volatility and high drawdown risk
Key Metrics & Analysis
Financial Health
Revenue Growth0.20%
Profit Margin-0.34%
P/E Ratio5.7
ROE-3.28%
ROA2.43%
Debt/Equity664.39
P/B Ratio1.0
Op. Cash Flow$411.6M
Free Cash Flow$-1237512448
Technical Analysis
TrendNeutral
RSI41.8
Support$5.07
Resistance$6.46
MA 20$5.67
MA 50$6.95
MA 200$6.04
MACDBullish
VolumeStable
Fear & Greed Index65.98
Valuation
Fair Value$1.35
Target Price$9.64
Upside/Downside71.75%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.50
Volatility68.71%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.